News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alexion Pharmaceuticals Inc. (ALXN) Reports First Quarter 2014 Results


4/24/2014 7:11:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results and a development pipeline update for the three months ended March 31, 2014. The Company reported net product sales of SolirisĀ® (eculizumab) of $566.6 million, including reimbursement of prior year shipments related to an agreement with the French government of $87.8 million, an increase of 67 percent from the same period in 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES